Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Pozycja w akcjach #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Cena akcji
$7.15
Kapitalizacja rynkowa
$313.60M
Zmiana (1 dzień)
-2.12%
Zmiana (1 rok)
-84.14%
Kraj
DE
Handel Anbio Biotechnology Class A Ordinary Shares (NNNN)

Kategoria

Historia ceny akcji dla Anbio Biotechnology Class A Ordinary Shares (NNNN)
Najwyższa cena zamknięcia: $7.15 dnia 2026-09-01

Najniższa cena zamknięcia: $6.12 dnia 2025-02-01
Historia cen akcji firmy Anbio Biotechnology Class A Ordinary Shares od 2025 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -23.17%
2025 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$368.46 -22.15%
US
$188.84 -37.67%
FR
$162.52 24.14%
JP
$187.34 23.49%
US
$75.35 -5.80%
CH